251 related articles for article (PubMed ID: 3156669)
1. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
Morikawa K; Takeda R; Yamazaki M; Mizuno D
Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators.
Morikawa K; Kamegaya S; Yamazaki M; Mizuno D
Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672
[TBL] [Abstract][Full Text] [Related]
3. Calcium-dependent and -independent tumoricidal activities of polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and phorbol myristate acetate in mice.
Morikawa K; Noguchi T; Yamazaki M; Mizuno D
Cancer Res; 1986 Jan; 46(1):66-70. PubMed ID: 3079591
[TBL] [Abstract][Full Text] [Related]
4. Tumor cytotoxicity of polymorphonuclear leukocytes in beige mice: linkage of high responsiveness to linear beta-1,3-D-glucan with the beige gene.
Fukase S; Inoue T; Arai S; Sendo F
Cancer Res; 1987 Sep; 47(18):4842-7. PubMed ID: 3621179
[TBL] [Abstract][Full Text] [Related]
5. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
[TBL] [Abstract][Full Text] [Related]
7. Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators.
Morikawa K; Kikuchi Y; Abe S; Yamazaki M; Mizuno D
Gan; 1984 Apr; 75(4):370-8. PubMed ID: 6735035
[TBL] [Abstract][Full Text] [Related]
8. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
[TBL] [Abstract][Full Text] [Related]
9. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
Sasaki T; Abiko N; Sugino Y; Nitta K
Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro cytolytic effect of hepatic, splenic and peritoneal macrophages from glucan-treated mice on sarcoma M5076.
Sherwood ER; Williams DL; Di Luzio NR
Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):157-61. PubMed ID: 3713379
[TBL] [Abstract][Full Text] [Related]
13. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
14. Glucan stimulates production of antitumor cytolytic/cytostatic factor(s) by macrophages.
Sherwood ER; Williams DL; Di Luzio NR
J Biol Response Mod; 1986 Dec; 5(6):504-26. PubMed ID: 3794756
[TBL] [Abstract][Full Text] [Related]
15. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
Cordier G; Samarut C; Revillard JP
Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
[TBL] [Abstract][Full Text] [Related]
16. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).
Araki A; Inoue T; Kimura S; Fukase S; Sendo F
Jpn J Cancer Res; 1990 Jan; 81(1):69-78. PubMed ID: 2108949
[TBL] [Abstract][Full Text] [Related]
20. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
Watabe S; Sendo F; Kimura S; Arai S
J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
